A long-term, open-label trial of the safety and efficacy of etanercept (25 mg twice weekly) in patients with rheumatoid arthritis (interim analysis).

被引：0
|
作者：
Wajdula, J
Pedersen, R
Sanda, M
机构：
来源：
ARTHRITIS AND RHEUMATISM | 2000年 / 43卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
974
引用
收藏
页码：S229 / S229
页数：1
相关论文
共 50 条
  • [31] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    [J]. Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [32] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, A.
    Wells, A. F.
    Vargas, J. Ignacio
    Baraf, H. S. B.
    Rischmueller, M.
    Klaff, J.
    Khan, N.
    Li, Y.
    Carter, K.
    Friedman, A.
    Durez, P.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 620 - 621
  • [33] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Kivitz, Alan
    Wells, Alvin F. F.
    Vargas, Juan I. I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    [J]. RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
  • [34] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
    Kivitz, Alan
    Wells, Alvin F.
    Vargas, Juan I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    [J]. RHEUMATOLOGY, 2023, 62
  • [35] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Ruediger B. Mueller
    Hendrik Schulze-Koops
    Daniel E. Furst
    Stanley B.  Cohen
    Kenneth Kwok
    Lisy Wang
    Tim Killeen
    Johannes von Kempis
    [J]. Clinical Rheumatology, 2022, 41 : 1045 - 1055
  • [36] Effect of dose adjustments on the efficacy and safety of tofacitinib in patients with rheumatoid arthritis: a post hoc analysis of an open-label, long-term extension study (ORAL Sequel)
    Mueller, Ruediger B.
    Schulze-Koops, Hendrik
    Furst, Daniel E.
    Cohen, Stanley B.
    Kwok, Kenneth
    Wang, Lisy
    Killeen, Tim
    von Kempis, Johannes
    [J]. CLINICAL RHEUMATOLOGY, 2022, 41 (04) : 1045 - 1055
  • [37] Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study
    Taylor, P.
    Genovese, M.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    Lundmark, J.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2014, 43 : 59 - 59
  • [38] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long- Term Extension Study in Patients with Rheumatoid Arthritis
    Magloire, Annaise
    Keystone, Edward
    Taylor, Peter
    Genovese, Mark
    Schlichting, Douglas
    de la Torre, Inmaculada
    Beattie, Scott
    Rooney, Terence
    [J]. SWISS MEDICAL WEEKLY, 2015, 145 : 4S - 5S
  • [39] Safety of long-term tacrolimus therapy for rheumatoid arthritis: an open-label, uncontrolled study in non-elderly patients
    Kawai, Shinichi
    Tanaka, Kortaro
    Ohno, Iwao
    Utsunomiya, Kazunori
    Seino, Yoshihiko
    [J]. MODERN RHEUMATOLOGY, 2008, 18 (04) : 345 - 353
  • [40] BARICITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS: SAFETY AND EFFICACY IN OPEN-LABEL, LONG-TERM EXTENSION STUDY
    Taylor, P.
    Genovese, M. C.
    Keystone, E.
    Schlichting, D.
    Beattie, S.
    Macias, W.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 65 - 66
12345